CVS Health (NYSE:CVS – Free Report) had its price target trimmed by Piper Sandler from $72.00 to $64.00 in a research report sent to investors on Monday,Benzinga reports. The brokerage currently has an overweight rating on the pharmacy operator’s stock. A number of other equities research analysts also recently issued reports on CVS. Evercore ISI […]